Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial-Reference-Cited by-同舟云学术

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

Published:2019-04-11 Issue:11 Volume:104 Page:2241-2248
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Bruna Riccardo,Benedetti Fabio,Boccomini Carola,Patti Caterina,Barbui Anna Maria,Pulsoni Alessandro,Musso Maurizio,Liberati Anna Marina,Gini Guido,Castellino Claudia,Rossini Fausto,Ciceri Fabio,Rota-Scalabrini Delia,Stelitano Caterina,Di Raimondo Francesco,Tucci Alessandra,Devizzi Liliana,Zoli Valerio,Zallio Francesco,Narni Franco,Dondi Alessandra,Parvis Guido,Semenzato Gianpietro,Lanza Francesco,Perrone Tommasina,Angrilli Francesco,Billio Atto,Gueli Angela,Mantoan Barbara,Rambaldi Alessandro,Gianni Alessandro Massimo,Corradini Paolo,Passera Roberto,Ladetto Marco,Tarella Corrado

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose chemotherapy with transplantation of autologous hematopoietic stem cells in the first line of follicular lymphoma therapy;Russian journal of hematology and transfusiology;2023-11-16

2. Measurable Residual Disease Monitoring in Lymphoma;Current Hematologic Malignancy Reports;2023-11-06

3. Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?;Mediterranean Journal of Hematology and Infectious Diseases;2023-02-28

4. Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience;Hematological Oncology;2023-02-17

5. Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma;British Journal of Haematology;2023-01-10